185 related articles for article (PubMed ID: 15976771)
21. Periodontal disease severity is related to high levels of C-reactive protein in pre-eclampsia.
Herrera JA; Parra B; Herrera E; Botero JE; Arce RM; Contreras A; López-Jaramillo P
J Hypertens; 2007 Jul; 25(7):1459-64. PubMed ID: 17563569
[TBL] [Abstract][Full Text] [Related]
22. Dental infections and cardiovascular diseases: a review.
Mattila KJ; Pussinen PJ; Paju S
J Periodontol; 2005 Nov; 76(11 Suppl):2085-8. PubMed ID: 16277580
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline.
McCarty MF
Med Hypotheses; 1999 May; 52(5):465-77. PubMed ID: 10416955
[TBL] [Abstract][Full Text] [Related]
24. [C-reactive protein in cardiovascular risk evaluation].
Fabijanić D; Banić M; Kardum D
Lijec Vjesn; 2006; 128(5-6):167-74. PubMed ID: 16910418
[TBL] [Abstract][Full Text] [Related]
25. [C-reactive protein: cardiovascular issues of an acute-phase protein].
Amezcua-Guerra LM; Springall del Villar R; Bojalil Parra R
Arch Cardiol Mex; 2007; 77(1):58-66. PubMed ID: 17500194
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular disease and periodontal diseases: commonality and causation.
Dave S; Batista EL; Van Dyke TE
Compend Contin Educ Dent; 2004 Jul; 25(7 Suppl 1):26-37. PubMed ID: 15645884
[TBL] [Abstract][Full Text] [Related]
27. [C-reactive protein and atherothrombosis--a prognostic factor or a risk factor?].
Yosef-Levi IM; Grad E; Danenberg HD
Harefuah; 2007 Dec; 146(12):970-4, 996. PubMed ID: 18254451
[TBL] [Abstract][Full Text] [Related]
28. Genetic and environmental contributions to plasma C-reactive protein and interleukin-6 levels--a study in twins.
Wörns MA; Victor A; Galle PR; Höhler T
Genes Immun; 2006 Oct; 7(7):600-5. PubMed ID: 16900203
[TBL] [Abstract][Full Text] [Related]
29. C-reactive protein comes of age.
Verma S; Szmitko PE; Ridker PM
Nat Clin Pract Cardiovasc Med; 2005 Jan; 2(1):29-36; quiz 58. PubMed ID: 16265340
[TBL] [Abstract][Full Text] [Related]
30. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study.
Tzoulaki I; Murray GD; Lee AJ; Rumley A; Lowe GD; Fowkes FG
Circulation; 2005 Aug; 112(7):976-83. PubMed ID: 16087797
[TBL] [Abstract][Full Text] [Related]
31. [Periodontitis and cardiovascular diseases--review of publications].
Bochniak M; Sadlak-Nowicka J
Przegl Lek; 2004; 61(5):518-22. PubMed ID: 15515818
[TBL] [Abstract][Full Text] [Related]
32. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory biomarkers and cardiovascular risk: association or cause and effect?
Rao M; Jaber BL; Balakrishnan VS
Semin Dial; 2006; 19(2):129-35. PubMed ID: 16551290
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of C-reactive protein for heart disease in dialysis patients.
Wang AY
Curr Opin Investig Drugs; 2005 Sep; 6(9):879-86. PubMed ID: 16187687
[TBL] [Abstract][Full Text] [Related]
35. CRP, IL-6 and endothelin-1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early graft occlusion and late cardiovascular events?
Hedman A; Larsson PT; Alam M; Wallen NH; Nordlander R; Samad BA
Int J Cardiol; 2007 Aug; 120(1):108-14. PubMed ID: 17141340
[TBL] [Abstract][Full Text] [Related]
36. [The impact of periodontal infection on systemic inflammatory process and atherosclerosis].
Cabała A; Chomyszyn-Gajewska M; Drozdz W
Przegl Lek; 2006; 63(8):681-4. PubMed ID: 17441382
[TBL] [Abstract][Full Text] [Related]
37. Biological foundation for periodontitis as a potential risk factor for atherosclerosis.
Chun YH; Chun KR; Olguin D; Wang HL
J Periodontal Res; 2005 Feb; 40(1):87-95. PubMed ID: 15613084
[TBL] [Abstract][Full Text] [Related]
38. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
39. Periodontitis: from local infection to systemic diseases.
D'Aiuto F; Graziani F; Tetè S; Gabriele M; Tonetti MS
Int J Immunopathol Pharmacol; 2005; 18(3 Suppl):1-11. PubMed ID: 16848982
[TBL] [Abstract][Full Text] [Related]
40. Elevation of C-reactive protein and interleukin-6 in plasma of patients with aggressive periodontitis.
Sun XJ; Meng HX; Shi D; Xu L; Zhang L; Chen ZB; Feng XH; Lu RF; Ren XY
J Periodontal Res; 2009 Jun; 44(3):311-6. PubMed ID: 18842114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]